Benzinga··Vandana SinghFDA Issues Warning Letter to Medline Over Critical Quality System Failures at NY Facility
FDA flags Medline for quality lapses at New York facility producing angiographic syringes, citing manufacturing deficiencies and inadequate response to 221 complaints.
MDLNproduct recallmanufacturing deficiencies